A detailed history of Berkshire Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Berkshire Asset Management LLC holds 2,029 shares of BIIB stock, worth $302,361. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,029
Previous 2,029 -0.0%
Holding current value
$302,361
Previous $470,000 16.38%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $386,565 - $480,304
2,029 New
2,029 $470,000
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $2,120 - $2,677
-10 Reduced 0.48%
2,067 $445,000
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $7,345 - $8,842
-33 Reduced 1.56%
2,077 $537,000
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $23,810 - $26,873
-94 Reduced 4.26%
2,110 $542,000
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $89,456 - $103,369
-325 Reduced 12.85%
2,204 $627,000
Q1 2023

Jun 06, 2023

BUY
$256.56 - $292.34 $648,840 - $739,327
2,529 New
2,529 $703,000
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $86,637 - $119,464
-445 Reduced 15.91%
2,352 $628,000
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $154,720 - $183,991
-825 Reduced 22.78%
2,797 $570,000
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $11,626 - $14,648
60 Added 1.68%
3,622 $763,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $431,717 - $554,820
-1,928 Reduced 35.12%
3,562 $855,000
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $22,073 - $28,785
-78 Reduced 1.4%
5,490 $1.55 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $73,815 - $118,192
-285 Reduced 4.87%
5,568 $1.93 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $82,845 - $97,058
341 Added 6.19%
5,853 $1.64 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $786,982 - $1.18 Million
3,331 Added 152.73%
5,512 $1.35 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $29,654 - $34,239
-112 Reduced 4.88%
2,181 $619,000
Q2 2020

Aug 12, 2020

SELL
$258.66 - $342.55 $812,451 - $1.08 Million
-3,141 Reduced 57.8%
2,293 $613,000
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $863,008 - $1.09 Million
3,210 Added 144.33%
5,434 $1.72 Million
Q4 2019

Feb 12, 2020

BUY
$220.06 - $304.07 $14,744 - $20,372
67 Added 3.11%
2,224 $660,000
Q3 2019

Oct 07, 2019

SELL
$217.44 - $243.88 $24,570 - $27,558
-113 Reduced 4.98%
2,157 $502,000
Q2 2019

Jul 29, 2019

BUY
$219.29 - $241.72 $56,576 - $62,363
258 Added 12.82%
2,270 $531,000
Q1 2019

Apr 16, 2019

BUY
$216.71 - $338.96 $2,167 - $3,389
10 Added 0.5%
2,012 $476,000
Q4 2018

Jan 24, 2019

SELL
$278.5 - $352.75 $40,382 - $51,148
-145 Reduced 6.75%
2,002 $602,000
Q3 2018

Oct 12, 2018

BUY
$293.51 - $383.83 $3,522 - $4,605
12 Added 0.56%
2,147 $759,000
Q2 2018

Jul 17, 2018

BUY
$257.52 - $306.91 $84,724 - $100,973
329 Added 18.22%
2,135 $620,000
Q1 2018

May 01, 2018

SELL
$260.13 - $367.91 $16,648 - $23,546
-64 Reduced 3.42%
1,806 $495,000
Q4 2017

Jan 17, 2018

BUY
$307.64 - $344.58 $8,613 - $9,648
28 Added 1.52%
1,870 $596,000
Q3 2017

Oct 30, 2017

BUY
$281.15 - $329.69 $517,878 - $607,288
1,842
1,842 $577,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Berkshire Asset Management LLC Portfolio

Follow Berkshire Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.